← Back to Blog
peptide bioregulatorsvascular healthVentfortA-3blood vessel peptidesKhavinsoncardiovascular healthcirculationendothelial health

Ventfort A-3: The Blood Vessel Bioregulator for Vascular Health and Circulation

By Wylie Stevens, BSN, RN·

# Ventfort A-3: The Blood Vessel Bioregulator for Vascular Health and Circulation

In twenty years of nursing, I have watched more patients struggle with the consequences of vascular disease than almost any other health condition. Heart attacks, strokes, peripheral artery disease, chronic wounds that will not heal, cognitive decline from reduced cerebral blood flow. The common denominator is always the same: deteriorating blood vessels. Your cardiovascular system is a 60,000-mile network of blood vessels, and when that network breaks down, everything downstream suffers. That is why I find the research on Ventfort A-3, a vascular peptide bioregulator, so compelling.

What Is Ventfort A-3?

Ventfort is a peptide bioregulator containing a complex of low-molecular-weight peptides (molecular weight up to 10,000 Daltons) isolated from the vascular tissue, specifically the aorta, of young bovines aged up to 12 months. Each capsule contains 10 mg of active natural peptides produced using patented technology developed by Professor Vladimir Khavinson and the St. Petersburg Institute of Bioregulation and Gerontology.

The A-3 designation indicates its position in the Khavinson bioregulator classification system. Ventfort has been among the most extensively studied vascular peptide products, with clinical trials documenting its effects on cholesterol, vascular wall integrity, and overall cardiovascular health.

Why Blood Vessels Age and What Happens When They Do

The Anatomy of a Blood Vessel

To understand what Ventfort does, you need to understand what it is supporting. Blood vessels have three layers:

Tunica Intima (Inner Layer): Lined with endothelial cells that form a smooth, one-cell-thick barrier between blood and the vessel wall. These cells are not passive wallpaper. They actively regulate blood flow, clotting, immune responses, and vessel tone. The endothelium produces nitric oxide (NO), which relaxes blood vessels and keeps blood flowing smoothly.

Tunica Media (Middle Layer): Contains smooth muscle cells and elastic fibers that allow vessels to expand and contract with each heartbeat. This layer gives arteries their ability to absorb the pressure pulse from the heart and deliver steady flow to tissues.

Tunica Adventitia (Outer Layer): Provides structural support and contains the small blood vessels (vasa vasorum) that nourish the vessel wall itself.

The Vascular Aging Cascade

Endothelial Dysfunction: This is where vascular disease begins. Aging, combined with oxidative stress, inflammation, high blood sugar, and other factors, damages the endothelial cells. They produce less nitric oxide, become "stickier" to immune cells and platelets, and allow LDL cholesterol to penetrate into the vessel wall. Research published in the *Journal of the American College of Cardiology* has documented that endothelial dysfunction precedes and predicts cardiovascular events (Bonetti et al., "Endothelial dysfunction: a marker of atherosclerotic risk." *Arterioscler Thromb Vasc Biol.* 2003;23(2):168-175. PMID: 12588755).

Arterial Stiffness: With age, the elastic fibers in the tunica media degrade and are replaced by collagen. Arteries become stiffer, losing their ability to cushion blood pressure pulses. This increases systolic blood pressure, strains the heart, and damages delicate microvessels in the brain, kidneys, and eyes.

Atherosclerosis: Lipids, immune cells, and cellular debris accumulate in the vessel wall, forming plaques that narrow the lumen and can rupture, causing heart attacks and strokes. This is a progressive process that begins in early adulthood and accelerates with risk factors.

Microvascular Disease: The smallest blood vessels, capillaries and arterioles, deteriorate with age, reducing blood flow to tissues. This contributes to slow wound healing, cognitive decline, kidney disease, and the general deterioration of organ function that characterizes aging.

The Ventfort Clinical Research

The Landmark Clinical Study

The most significant clinical study of Ventfort was conducted at the Medical Center of the St. Petersburg Institute of Bioregulation and Gerontology between November 2003 and February 2004. Here are the details:

Study Population: 49 patients with atherosclerosis of various arteries and senile purpura (age-related fragile blood vessels)

**Study Design:**

  • Main group: 27 patients (15 men, 12 women) received Ventfort orally, 1-2 capsules 2-3 times daily for 10-15 days
  • Control group: 22 patients (11 men, 11 women) received only general-purpose medicines

Key Findings:

  1. Cholesterol Reduction: Ventfort administration resulted in a reliable decrease in general blood cholesterol levels. This was achieved without statin medications, through a mechanism that involves regulating the metabolic processes in vascular wall cells.
  1. Lipoprotein Regulation: The peptide bioregulator regulated blood content of lipoproteins, helping shift the balance from harmful LDL toward a healthier lipid profile.
  1. Vascular Wall Improvement: Ventfort improved the functional and morphological characteristics of the vascular wall, supporting structural integrity and normal function.
  1. Safety: Ventfort was well tolerated at oral administration with no side effects, no contraindications, and demonstrated suitability as an adjunct to complex treatment and prophylaxis of vascular disorders of various origins.

Endothelial Cell Research

Laboratory research on the peptides contained in Ventfort demonstrated stimulation of endotheliocyte (endothelial cell) proliferation. This finding is significant because the endothelium is the first line of defense against atherosclerosis. If vascular peptides can help maintain a healthy, intact endothelial layer, they may help prevent atherosclerosis at its earliest stage, before plaques ever begin to form.

The Vesugen Connection

Vesugen (Lys-Glu-Asp) is a synthetic tripeptide identified as one of the active components in vascular tissue extracts. Research on Vesugen has helped clarify the mechanisms by which vascular peptides work:

  • Vesugen is classified as a matrikine, an extracellular matrix-derived peptide that regulates cell activity
  • It interacts with DNA to influence gene expression in vascular cells
  • It has been studied for its effects on endothelial cell function, vascular smooth muscle regulation, and overall cardiovascular health

The relationship between Ventfort (the natural extract) and Vesugen (the synthetic active peptide) helps validate the bioregulator approach: the natural extract contains the active sequences, and the synthetic peptide confirms the mechanism.

How Ventfort Fits Into Cardiovascular Health

Ventfort vs. Conventional Cardiovascular Treatments

**Statins:**

  • Powerfully reduce LDL cholesterol through HMG-CoA reductase inhibition
  • Proven to reduce cardiovascular events in large clinical trials
  • Side effects include muscle pain, liver enzyme elevation, and increased diabetes risk
  • Work by a single mechanism (cholesterol synthesis inhibition)

**Blood Pressure Medications:**

  • Reduce pressure through various mechanisms (ACE inhibition, calcium channel blockade, etc.)
  • Essential for managing hypertension
  • Do not address the underlying vascular wall deterioration

**Ventfort (Peptide Bioregulation):**

  • Provides tissue-specific regulatory peptides for vascular cells
  • Addresses vascular wall integrity, endothelial function, and lipid metabolism simultaneously
  • No documented adverse effects
  • Works at the level of cellular regulation and gene expression
  • Designed to complement, not replace, conventional cardiovascular care

I want to be absolutely clear: Ventfort is not a replacement for prescribed cardiovascular medications. If your doctor has you on statins, blood pressure medication, or anticoagulants, continue taking them. Ventfort is a potential complementary approach that addresses vascular health at the cellular level, which is something conventional medications generally do not do.

Who Should Consider Ventfort A-3

Based on the clinical research and my understanding of vascular health, Ventfort may benefit:

  • Adults over 50 concerned about cardiovascular aging
  • People with borderline cholesterol looking for additional support alongside lifestyle changes
  • Those with a family history of cardiovascular disease who want proactive vascular support
  • Patients with atherosclerosis seeking complementary approaches (with physician approval)
  • People with poor circulation including cold extremities and slow wound healing
  • Anyone focused on longevity who understands that vascular health is foundational to healthy aging

Recommended Protocol

The clinical study used 1-2 capsules, 2-3 times daily for 10-15 days. The standard bioregulator cycling approach then recommends repeating this course every 3 to 6 months.

Some practitioners recommend a more standard protocol of 2 capsules daily for 30 days, repeated every 3-6 months, which aligns with the general bioregulator supplementation framework.

Synergistic Combinations

Ventfort + Heart Peptides: Supporting both the blood vessels and the heart muscle addresses the cardiovascular system comprehensively.

Ventfort + Brain Peptides: Cerebrovascular health directly impacts cognitive function. Supporting vascular health may help maintain blood flow to the brain.

Ventfort + PCC-17 (Adrenal): Chronic stress and elevated cortisol damage blood vessels. Supporting adrenal function may reduce one of the key drivers of vascular aging.

Building a Complete Vascular Health Protocol

Nutritional Foundations

Omega-3 Fatty Acids: EPA and DHA reduce inflammation, improve endothelial function, and support healthy triglyceride levels. Aim for 2-3 grams of combined EPA/DHA daily from fish oil or algae sources.

Nitric Oxide Support: Dietary nitrates from beets, leafy greens, and arugula are converted to nitric oxide, supporting endothelial function. L-citrulline supplementation also supports NO production.

Antioxidant-Rich Diet: Colorful fruits and vegetables provide polyphenols that protect the endothelium from oxidative damage. Berries, dark chocolate, green tea, and red wine (in moderation) are particularly beneficial.

Fiber: Soluble fiber from oats, beans, and psyllium helps manage cholesterol levels. Aim for 25-35 grams of total fiber daily.

Exercise for Vascular Health

Aerobic Exercise: Regular cardiovascular exercise is the single most powerful intervention for vascular health. It increases nitric oxide production, improves endothelial function, lowers blood pressure, and promotes healthy cholesterol profiles. Aim for 150 minutes of moderate or 75 minutes of vigorous activity weekly.

Resistance Training: Builds muscle that acts as a metabolic sink for glucose and supports healthy body composition. 2-3 sessions per week.

Flexibility and Blood Flow: Practices like yoga and stretching improve blood flow and may support vascular flexibility.

Key Supplements for Vascular Support

  • CoQ10: Supports mitochondrial function in heart and vascular cells, particularly important if taking statins
  • Magnesium: Relaxes blood vessel smooth muscle and supports healthy blood pressure
  • Vitamin K2: Directs calcium away from arteries and into bones, potentially reducing arterial calcification
  • Aged Garlic Extract: Clinical evidence supports modest blood pressure and cholesterol benefits
  • Bergamot Extract: Emerging research suggests benefits for lipid profiles

Risk Factor Management

No supplement can overcome unmanaged risk factors. The following are non-negotiable:

  • Do not smoke. Smoking is the single most destructive thing you can do to your blood vessels.
  • Manage blood sugar. Even prediabetic glucose levels damage the endothelium.
  • Control blood pressure. Sustained hypertension mechanically damages vessel walls.
  • Maintain healthy weight. Visceral fat is metabolically active and promotes systemic inflammation.
  • Manage stress. Chronic stress elevates cortisol, increases blood pressure, and promotes endothelial dysfunction.

Why Vascular Health Is the Foundation of Longevity

There is a saying in medicine: "You are as old as your arteries." Every organ in your body depends on blood flow for oxygen and nutrients. When vascular health declines, everything declines:

  • Brain: Reduced cerebral blood flow contributes to cognitive decline and dementia
  • Heart: Coronary artery disease is the leading cause of death worldwide
  • Kidneys: Renal artery disease leads to kidney failure
  • Eyes: Retinal vascular disease causes vision loss
  • Extremities: Peripheral artery disease causes pain, wounds, and in severe cases, amputation
  • Sexual function: Erectile dysfunction is often an early sign of vascular disease

Supporting vascular health is not just about preventing heart attacks. It is about maintaining the infrastructure that keeps every organ functioning.

My Assessment

Of all the Khavinson peptide bioregulators, Ventfort A-3 may have the strongest clinical evidence base. A controlled clinical trial with documented improvements in cholesterol, lipoproteins, and vascular wall integrity provides more than just mechanistic theory. It provides clinical data showing real patient outcomes.

The safety profile is clean, the mechanism is sound, and the target, vascular health, is arguably the most important determinant of healthy aging. For anyone serious about longevity and cardiovascular wellness, Ventfort A-3 deserves a place in the conversation.

As always, this is a complement to, not a substitute for, conventional cardiovascular care, healthy lifestyle practices, and regular medical monitoring.

Support Your Vascular Health

Explore Ventfort A-3 and our complete range of research-backed peptide bioregulators in our [shop](/shop). Your blood vessels are the foundation of your health. Give them the support they deserve.

---

References:

  1. Clinical Study Report: Biologically Active Peptide Bioregulator Ventfort. *Medical Center, St. Petersburg Institute of Bioregulation and Gerontology*, 2003-2004.
  2. Khavinson, V.Kh. "Peptides and Ageing." *Neuroendocrinology Letters*, 2002;23 Suppl 3:11-144.
  3. Bonetti, P.O. et al. "Endothelial dysfunction: a marker of atherosclerotic risk." *Arterioscler Thromb Vasc Biol.* 2003;23(2):168-175. PMID: 12588755.
  4. Vesugen (Lys-Glu-Asp) classification and mechanism. *Wikipedia: Vesugen*. Accessed 2026.
  5. Lakatta, E.G. & Levy, D. "Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises." *Circulation.* 2003;107(1):139-146. PMID: 12515756.
  6. Seals, D.R. et al. "You're only as old as your arteries: translational strategies for preserving vascular endothelial function with aging." *Physiology.* 2014;29(4):250-264. PMID: 24985329.

---

*Disclaimer: This article is for educational purposes only and does not constitute medical advice. Peptide bioregulators are sold as dietary supplements and have not been evaluated by the FDA to diagnose, treat, cure, or prevent any disease. Ventfort A-3 is not a replacement for prescribed cardiovascular medications including statins, blood pressure medications, or blood thinners. Do not discontinue any prescribed medication without consulting your physician. Always consult your healthcare provider before starting any new supplement, especially if you have cardiovascular disease, take prescription medications, or have risk factors for heart disease or stroke. The research cited reflects the current state of scientific investigation, and individual results may vary.*

Disclaimer: This content is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before making health decisions.